Blood Plasma Derivatives Market Trends
Blood plasma derivatives are used in a variety of clinical settings. Several treatments rely on blood plasma derivatives as a key ingredient.
The blood plasma derivatives market trends report expects the industry size to reach USD 40, 475.8 million by 2030 at 10.50% CAGR during the forecast period 2022-2030.
The need for blood plasma derivatives is being driven by the world’s aging population. Major illnesses are more prevalent in the aged population, necessitating medical attention and accelerating market expansion.
Another problem is that the high cost of medicines based on plasma derivatives as well as the potential for negative side effects from plasma replacement therapy restrain the growth of the global blood plasma derivatives industry.
Regional Analysis
Blood plasma derivatives are expected to see the fastest growth in the Asia Pacific region. The market is expanding as a result of rising awareness and a rising occurrence of fatal diseases.
The rise in fatal blood-related disorders has a substantial impact on the expansion of the global market for blood plasma derivatives. Due to the strain that the rise in diseases like cancer, HIV, and other conditions is placing on the global healthcare system, blood plasma derivatives must be used in treatment.
Blood plasma derivatives are concentrated forms of certain plasma proteins obtained through the fractionation process from a pool of plasma donors. They are used to treat a variety of deadly diseases.
Segmentation
The global blood plasma derivatives market has been classified into three segments: type, application, and end user. The market is divided into anti-thrombin, fresh frozen plasma (FFP), intravenous immunoglobulin (IVIG), albumin, and others. Factor VII, Factor IX, and Alpha 1 proteinase inhibitor concentrate are examples of other forms.
By application, the market has been segmented into Hemophilia A, Hemophilia B, HIV, Hepatitis B, Hepatitis C, Thrombocytosis, and others. Other application includes Von Willebrand disease.
By end user, the market has been segmented into blood transfusion centers,
hospitals, diagnostic centers, clinics, and others.
Competitive Landscape
Fusion Healthcare (India), Octapharma AG (Switzerland), Baxter International Inc. (US), Bain Capital, LLC (US), Grigols (Spain), Kedrion S.p.A (Italy), SK Plasma Co., Ltd. (South Korea), Biotest AG (Germany), and CSL Limited (Australia) are some of the prominent companies who are leading as the global players holding the blood plasma derivatives market share.
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Contact Us:
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5Th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
Email: sales@marketresearchfuture.com
Website: https://www.marketresearchfuture.com